Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01144793 · ClinicalTrials.gov registry record
Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 17
- Enrollment target
NCT01144793: Completed study, sponsored by Stanford University.
NCT01144793 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01144793 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to measure, in pilot/observational study, panels of circulating proteins in real time at the onset of neutropenic fever/infection in patients with acute or chronic leukemias undergoing chemotherapy or other biologic treatment. And to generate preliminary trend results in panels of circulating proteins longitudinally during the period of neutropenia and to correlate those values to clinical/laboratory data and patient outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2008-04 |
| Est. Completion | 2008-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01144793
The ClinicalTrials.gov registry entry for NCT01144793 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01144793 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01144793 about?
NCT01144793 is a clinical study titled "Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias". The purpose of this study is to measure, in pilot/observational study, panels of circulating proteins in real time at the onset of neutropenic fever/infection in patients with acute or chronic leukemias undergoing chemotherapy or other biologic treatment. And to generate preliminary trend results in...
What is the current status of trial NCT01144793?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2008-04. Estimated completion is 2008-06.
Who is sponsoring clinical trial NCT01144793?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.